Navigation Links
Optimer Pharmaceuticals Announces Presentation at SHEA of Data Highlighting the Burden of Clostridium difficile Infection (CDI) in Hospital Patients
Date:4/2/2011

SAN DIEGO, April 2, 2011 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today the presentation of information from insurance claims and survey databases highlighting the unmet need for targeted therapies to treat subpopulations at high risk of recurrence of Clostridium difficile infection (CDI).  The research also presented the substantial mortality and frequent complications associated with CDI.  Investigator Erik R. Dubberke, M.D., M.S.P.H., of the Washington University School of Medicine, St. Louis, Missouri, presented data at the 21st Annual Scientific Meeting of The Society for Healthcare Epidemiology of America (SHEA) in Dallas, Texas.  Data for this research were obtained from the 2008 Nationwide Inpatient Sample, 2009 Medicare Provider Analysis and Review file, Florida fiscal year 2006-2007 Medicaid claims and 2007-2008 Medicare 5% Standard Analytical Files.

(Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)

Dr. Dubberke presented the demographic and clinical characteristics of hospital inpatient CDI cases showing that the average CDI patient was 68 years old, more than half were female, and in total, 83% of CDI cases surveyed were from at least one of the following subpopulations: patients with renal impairment (36%), patients aged greater than age 80 (34%), patients aged 65-79 (33%), cancer patients (16%), inflammatory bowel disease patients (5%), organ transplant patients (2%), human immunodeficiency virus (HIV) patients (1%), or bone marrow transplant patients (0.4%).  Each of these subpopulations are considered to be at high risk of recurrence or mortality from CDI.

Dr. Dubberke also presented data showing that Medicare was the largest payer in the CDI cases surveyed (68%), followed by private insurance (19%), and Medic
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin
2. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
3. Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
4. Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI)
5. Optimer Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
6. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
7. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
8. Optimer Pharmaceuticals to Present at September 2010 Investor Conferences
9. Optimer Pharmaceuticals Announces Presentations of Additional Fidaxomicin Phase 3 Data at Upcoming ICAAC Annual Meeting
10. Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
11. Optimer Pharmaceuticals to Host Investor and Analyst Event on November 18
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014  Hill-Rom Holdings, Inc. ... to a management presentation at the Morgan Stanley Global ... EDT. You are invited to listen to ... http://ir.hill-rom.com/events.cfm or access it directly at http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP ... available one hour after conclusion of the live event ...
(Date:8/27/2014)... 2014 Sihuan Pharmaceutical Holdings Group Ltd. ... leading pharmaceutical company with the largest cardio-cerebral vascular ... prescription drug market, today announced the unaudited ... (collectively the "Group") for the six months ended ... HighlightsFor the Six months ended 30 JuneKey Income ...
(Date:8/27/2014)... , Aug. 27, 2014  CVS Caremark (NYSE: ... into a new clinical affiliation with MedStar Health, a ... Maryland and the Washington, ... high-quality, affordable health care services for patients. Through this ... access to clinical support, medication counseling, chronic disease monitoring ...
Breaking Medicine Technology:Sihuan Pharmaceutical Announces 2014 Interim Results 2Sihuan Pharmaceutical Announces 2014 Interim Results 3Sihuan Pharmaceutical Announces 2014 Interim Results 4Sihuan Pharmaceutical Announces 2014 Interim Results 5Sihuan Pharmaceutical Announces 2014 Interim Results 6Sihuan Pharmaceutical Announces 2014 Interim Results 7CVS Caremark Announces New Clinical Affiliation with MedStar Health 2CVS Caremark Announces New Clinical Affiliation with MedStar Health 3
... 2010 Curemark LLC , a drug research and ... today that it has been awarded a grant by the ... Program to advance the development of its lead product CM-AT ... at 18 sites around the US. The QTDP ...
... VALLEY, Calif., Nov. 2, 2010 Spectros Corporation ... with the T-Stat VLS Tissue Oximeter at the ... newly released data was presented during poster sessions ... Circulation: Pharmacology/Physiology", held at the American Society of ...
Cached Medicine Technology:Curemark Awarded Qualifying Therapeutic Discovery Project (QTDP) Grant 2Spectros Presents New Clinical Studies Using T-Stat VLS Tissue Oximeter at Anesthesiology 2010 2
(Date:8/27/2014)... August 27, 2014 Taking its popular obstacle ... Steele Creek YMCA will host its largest crowd at ... Saturday, September 13 at YMCA Camp Thunderbird . ... divisions: adult, youth and teams. Within each division, runners ... their physical limit - for a worthy cause. All ...
(Date:8/27/2014)... 27, 2014 Reviewing the prices that ... be easier for the public when using the Quotes ... promoted in all 50 states in the U.S. are ... different insurers that are generating the rates information from ... adults to use the programmed system without charge. Because ...
(Date:8/27/2014)... Shawna's new book, released in ebook ... Digging, which a brand-new technique she created. Seed digging ... to bring permanent healing quickly. , According to Burns, ... disorders cured on a daily basis. It teaches people ... find incredible inner peace with only a few simple ...
(Date:8/27/2014)... The New York Mobility Club (sponsored ... events about “ Sexuality & Intimacy ” for people ... and entertaining discussions are for mature audiences only. September ... Avenue, Mamaroneck, NY) and October 7 from 6-8 pm ... , The New York Mobility Club is a local ...
(Date:8/27/2014)... 2014 Top 10 Best SEO Hosting, a ... hosting suppliers and announced iPage, Bluehost and GoDaddy are the ... Australia and Europe to buy useful hosting (including VPS and ... suppliers, iPage has been serving hosting small business ... has grown into a leader in the hosting industry for ...
Breaking Medicine News(10 mins):Health News:C2 Survival Racers Go to Extremes to Provide Kids with YMCA Programs 2Health News:Home Insurance Prices for All 50 States Now Supplied at Consumer Insurance Portal Online 2Health News:Shawna Burns, Counselor, Releases Debut Book, "Seed Digging," to Improve Lives of Children and Adults with Addictions and Mental Health Disorders 2Health News:Bussani Mobility Sponsors New York Mobility Club Meetings September 9 & October 7 for People with Disabilities, Sexuality & Intimacy Discussed by Advocate Liz Treston 2Health News:Well-known SEO Hosts Review Site Top10BestSEOHosting.com Recommends iPage, Bluehost and GoDaddy To Webmasters 2
... BIRMINGHAM, Ala., Sept. 8 BioCryst Pharmaceuticals, Inc. (Nasdaq: ... summaries at two upcoming investor conferences. , , ... is scheduled to present a corporate summary at the Rodman & ... 2:25 p.m. Eastern Time. The conference will be held September 9-11, ...
... ... Use in Epocrates Survey , ... San Mateo, CA (PRWEB) September 8, 2009 -- Epocrates, Inc., a leading provider ... role of technology use in hospitals and clinics across the nation. , , ,The majority ...
... , , , ... on its recent analysis of the dairy animal nutrition market, ... business of Church & Dwight Company Incorporated, with the 2009 ... the Year Award. It acknowledges the company,s excellence in developing ...
... , , LONDON, Sept. ... Ingredients Excellence in Financial & Risk Management Award is presented ... the first and only EU-and FDA-approved omega-3 derived prescription drug. ... the USA, the product is a prescribed adjunct to diet ...
... ... in using electronic cigarette, the private research group has recently completed survey of 10,000 ... ... is a battery-powered device that provides inhaled doses of nicotine by delivering a vaporized ...
... ... testimonial for ColorAlchemy by licensed Marriage and Family Therapist and Clinical Hypnotherapist David Swindoll now ... ... Therapist and Clinical Hypnotherapist for over thirty years. He has found the use of ColorAlchemy ...
Cached Medicine News:Health News:BioCryst Executives to Present at Two Investor Conferences 2Health News:Nurses Facing National Shortage Turn to Mobile Technology to Support Patient Care 2Health News:Frost & Sullivan Cites Arm & Hammer for Excellence in the Dairy Animal Nutrition and Management Market 2Health News:Frost & Sullivan Cites Arm & Hammer for Excellence in the Dairy Animal Nutrition and Management Market 3Health News:Frost & Sullivan Cites Arm & Hammer for Excellence in the Dairy Animal Nutrition and Management Market 4Health News:Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova BioPharma 2Health News:Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova BioPharma 3Health News:Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova BioPharma 4Health News:Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova BioPharma 5Health News:Electronic Cigarette Known as ecig Helps You Quit Smoking 2Health News:Electronic Cigarette Known as ecig Helps You Quit Smoking 3Health News:Licensed Marriage and Family Therapist and Clinical Hypnotherapist Provides Powerful Video Testimony for ColorAlchemy and Color Therapy 2Health News:Licensed Marriage and Family Therapist and Clinical Hypnotherapist Provides Powerful Video Testimony for ColorAlchemy and Color Therapy 3
... for urinary albumin that allows for early ... CLIA Waived test has a sensitivity of ... gives accurate results in only 3 minutes ... hours. Since early detection is one key ...
... Drug Screen Tests are available in 14 ... (Ecstasy). Designed using Microgenics Antibody Technology, the ... point of care immunoassay targeted to detect ... MDA and MDEA but no cross-reactivity to ...
Accu-Stat Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP)....
... Screen Tests are available in 14 configurations ... Designed using Microgenics Antibody Technology, the SureStep™ ... of care immunoassay targeted to detect MDMA ... and MDEA but no cross-reactivity to any ...
Medicine Products: